Impax Asset Management Group plc Buys 1,577 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Impax Asset Management Group plc lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 43.9% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,167 shares of the medical equipment provider’s stock after acquiring an additional 1,577 shares during the period. Impax Asset Management Group plc’s holdings in Intuitive Surgical were worth $2,538,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Oak Harbor Wealth Partners LLC raised its position in shares of Intuitive Surgical by 4.0% in the third quarter. Oak Harbor Wealth Partners LLC now owns 833 shares of the medical equipment provider’s stock valued at $409,000 after purchasing an additional 32 shares during the period. Sycomore Asset Management grew its stake in Intuitive Surgical by 63.0% in the 3rd quarter. Sycomore Asset Management now owns 14,866 shares of the medical equipment provider’s stock valued at $7,230,000 after buying an additional 5,746 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. raised its holdings in Intuitive Surgical by 6.7% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 10,021 shares of the medical equipment provider’s stock worth $4,923,000 after acquiring an additional 632 shares during the period. Black Swift Group LLC acquired a new position in Intuitive Surgical during the 3rd quarter worth $3,242,000. Finally, Metis Global Partners LLC boosted its holdings in Intuitive Surgical by 3.2% during the third quarter. Metis Global Partners LLC now owns 16,127 shares of the medical equipment provider’s stock valued at $7,923,000 after acquiring an additional 505 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 1.9 %

NASDAQ ISRG opened at $527.61 on Friday. The firm has a market cap of $187.92 billion, a price-to-earnings ratio of 84.82, a PEG ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $295.02 and a 1-year high of $544.38. The company has a 50 day moving average of $499.29 and a 200-day moving average of $457.89.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In related news, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the sale, the general counsel now directly owns 1,595 shares of the company’s stock, valued at $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 396 shares of Intuitive Surgical stock in a transaction on Monday, August 26th. The stock was sold at an average price of $486.88, for a total transaction of $192,804.48. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,680,761.28. This represents a 6.71 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 91,178 shares of company stock worth $45,897,071. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on ISRG. BTIG Research set a $535.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price target for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.